Summary
Paracetamol (acetaminophen) poisoning accounts for almost a third of admissions to our district poisons unit, and is the commonest cause of death in such patients. Antidotal treatment may be effective up to 10h after overdose with oral methionine or up to 24h with acetylcysteine (not 15h as previously suggested for the latter). Patients taking paracetamol overdose while also receiving drugs which induce hepatic enzymes are more susceptible to liver damage, and antidotal treatment may be necessary at lower plasma paracetamol concentrations (50% of the normal treatment line). As survival following liver transplantation is now increasing, it is important to identify early prognostic indicators in fulminant hepatic failure, so that those patients with a high chance of fatal outcome can be considered for transplantation. Useful indicators are the presence of acidosis, marked prolongation of prothrombin time or a continued rise in prothrombin time on day 4 after the overdose. There is no evidence that paracetamol or acetylcysteine are teratogenic in pregnancy. Delays in administering acetylcysteine after paracetamol poisoning in pregnancy have been shown to increase the risk of spontaneous abortion and fetal death. Thus, acetylcysteine should be started as early as possible where treatment is indicated.
References
Bateman DN, Woodhouse KW, Rawlins MD. Adverse reactions to N-acetylcysteine. Human Toxicology 3: 393–398, 1984
Bismuth H, Samuel D, Gugenheim J, Castaing D, Bernuaus, et al. Emergency liver transplantation for fulminant hepatitis. Annals of Internal Medicine 107: 337–341, 1987
Boobis AR, Tee LBG, Hampden CE, Davies DS. Freshly isolated hepatocytes as a model for studying the toxicity of paracetamol. Food and Chemical Toxicology 24: 731–736, 1986
Brahams D. Paracetamol overdose: timing the antidote. Lancet 1: 567–568, 1989
Canalese J, Gimson AES, Davis M, Williams R. Factors contributing to mortality in paracetamol-induced hepatic failure. British Medical Journal 282: 199–202, 1981
Davis M, Simmons CJ, Harrison NG, Williams R. Paracetamol overdose in man: relationship between pattern of urinary metabolites and severity of liver damage. Quarterly Journal of Medicine 45: 181–191, 1976
Editorial. Management of serious paracetamol poisoning. Drugs and Therapeutics Bulletin 26: 97–99, 1988
Edmond J, Aran P, Thistlewaite J, Broelsch P, Whitington P, Baker A. Liver transplantation and the management of fulminant hepatic failure. Gastroenterology 94: A537, 1988
Ellenhorn MJ, Barceloux DG. Acetaminophen (paracetamol). In Medical toxicology, pp. 156–166, Elsevier Science Publishing Company, New York, 1988
Fernandez E, Fernandez-Brito AC. Acetaminophen toxicity. New England Journal of Medicine 296: 577, 1977
Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Improved outcome of paracetamol induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 335: 1572–1573, 1990a
Harrison PM, O’Grady JG, Keays RT, Alexander GJM, Williams R. Serial prothrombin time as a prognostic indicator in paracetamol induced fulminant hepatic failure. British Medical Journal 301: 964–966, 1990b
Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. New England Journal of Medicine 324: 1852–1857, 1991
Jaeschke H, Mitchell JR. Neutrophil accumulation exacerbates acetaminophen-induced liver injury. FASEB Journal 3: A920, 1989
Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, et al. Acetaminophen-induced hepatic necrosis: II. Role of covalent binding in vivo. Journal of Pharmacology and Experimental Therapeutics 187: 195–202, 1973
Keays AT, Gove C, Forbes A, Alexander CJM, Williams R. Use of late N-acetylcysteine in severe paracetamol overdose. Gut 30: A1512, 1989
Malia RG, Kennedy HJ, Park BK, Triger DR, Preston FE. The effect of acetominophen on the vitamin K dependent prothrombin complex. Thrombosis and Haemostasis 54: 205, 1985
Mant TGK, Tempowski JH, Volans GN, Talbot JCC. Adverse reactions to acetylcysteine: effects of overdose. British Medical Journal 289: 217–219, 1984
McClain CJ, Kromhout JP, Peterson FJ, Holtzman JL. Potentiation of acetaminophen toxicity by alcohol. Journal of the American Medical Association 244: 251–253, 1980
McElhatton PR, Sullivan FM, Smith SE, Volans GN. Paracetamol poisoning in pregnancy. Teratology 42: 17A, 1990a
McElhatton PR, Sullivan FM, Volans GN, Fitzpatrick R. Paracetamol poisoning in pregnancy: an analysis of the outcomes of cases referred to the Teratology Information Service of the National Poisons Information Service. Human and Experimental Toxicology 9: 147–153, 1990b
Meredith TJ, Prescott LF, Vale JA. Why do patients still die from paracetamol poisoning? British Medical Journal 193: 345–346, 1986
Miner DJ, Kissinger PT. Evidence for the involvement of N-acetyl-p-quinoneimine in acetaminophen metabolism. Biochemical Pharmacology 28: 3285–3290, 1979
Minton NA, Henry JA, Frankel RJ. Fatal paracetamol poisoning in an epileptic. Human Toxicology 7: 33–34, 1988
Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis: IV. Protective role of glutathione. Journal of Pharmacology and Experimental Therapeutics 187: 211–217, 1973
Mitchell JR, Thorgeirsson SS, Potter WZ, Jollow DJ, Reiser H. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clinical Pharmacology and Therapeutics 16: 676–684, 1974
Moore M, Thor H, Moore G, Nelson S, Moldeus P, Orrenius S. The toxicity of acetaminophen and N-acetyl-p-benzopquinone-imine (NABQI) in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca++. Journal of Biological Chemistry 260: 13035–13040, 1985
Office of Population Censuses and Surveys. Mortality statistics — accidents and violence. London: HMSO, 1989
O’Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97: 439–445, 1989
O’Grady JG, Gimson AES, O’Brien CJ, Pucknell A, Hughes RD, et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94: 1186–1192, 1988
Parker D, White JP, Paton D, Routledge PA. Safety of late acetylcysteine treatment in paracetamol poisoning. Human and Experimental Toxicology 9: 25–27, 1990
Peleman RR, Gavaler JS, Van Thiel D, Esquivel C, Gordon R, et al. Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 7: 484–489, 1987
Phear EA, Ruebner B, Sherlock S, et al. Methionine toxicity in liver disease and its prevention by chlortetracycline. Journal of Clinical Science 15: 93–117, 1956
Potter WZ, Davis DC, Mitchell JR, Jollow DJ, Gillette JR, et al. Acetaminophen-induced hepatic necrosis: III. Cytochrome P-450-mediated covalent binding in vitro. Journal of Pharmacology and Experimental Therapeutics 187: 203–210, 1973
Prescott LF. Prevention of hepatic necrosis following paracetamol overdosage. Health Bulletin 36: 204–212, 1978
Prescott LF. Paracetamol overdosage: pharmacological considerations and clinical management. Drugs 25: 290–314, 1983
Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. European Journal of Clinical Pharmacology 37: 501–506, 1989
Prescott LF, Illingworth RN, Critchley JAJH, Stewart MJ, Adam RD, et al. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. British Medical Journal 2: 1097–1100, 1979
Prescott LF, Matthew H. Cysteamine for paracetamol overdosage. Lancet 1: 998, 1974
Proudfoot AT. Diagnosis and management of acute poisoning, Blackwell, Oxford, 1982
Rappoport AM. Physioanatomical basis of toxic liver injury. In Faber & Fisher (Eds) Toxic injury of the liver, Part A, pp. 1–57, Marcel Dekker, New York, 1979
Riggs BS, Bronstein AC, Kulig K, Archer PG, Rumack BH. Acute acetaminophen overdose during pregnancy. Obstetrics and Gynecology 74: 247–253, 1989
Roberts I, Robinson MJ, Mughal MZ, Ratcliffe JG, Prescott LF. Paracetamol metabolites in the neonate following maternal overdose. British Journal of Clinical Pharmacology 18: 201–206, 1984
Rollins DE, von Bahr C, Glaumann H, Moldeus P, Rane A. Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells. Science 205: 1414–1416, 1979
Slattery JT, Levy G. Reduction of acetaminophen toxicity by sodium sulphate in mice. Research Communications in Chemical Pathology and Pharmacology 18: 167–170, 1977
Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. New England Journal of Medicine 319: 1557–1562, 1988
Smith JAE, Hine ID, Beck P, Routledge PA. Paracetamol toxicity: is enzyme induction important? Human Toxicology 5: 383–385, 1986
Tee LGB, Boobis AR, Davies DS. N-acetylcysteine for paracetamol overdose. Lancet 1: 331–332, 1986
Tenenbein M. Hypersensitivity-like reactions to N-acetylcysteine. Veterinary and Human Toxicology 26: 3–5, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Janes, J., Routledge, P.A. Recent Developments in the Management of Paracetamol (Acetaminophen) Poisoning. Drug-Safety 7, 170–177 (1992). https://doi.org/10.2165/00002018-199207030-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199207030-00002